TENOVUS CANCER CARE
Financial health, per its FY2024 accounts
The accounts state that the charity generated a surplus before investment gains of £858,239 and holds unrestricted reserves of £6.12m, which is above its stated policy target of £2.64m. The trustees confirmed that the use of the going concern basis of accounting is appropriate with no material uncertainties identified regarding the group's ability to continue.
What the accounts disclose
“The trustees have therefore set the reserves policy to offset these risks at £2.64m for the year end position.” — page 45
“We also reported a serious incident to the charity commission during the year which did result in the immediate cessation of a volunteer service to the charity with a subsequent prosecution from the police.” — page 28
“Tenovus Cancer Care has one wholly owned subsidiary, Tenovus Trading Limited. The company shares their registered office with Tenovus Cancer Care. Tenovus Trading Limited conducts trading activities, such as greetings cards and other purchased goods for sale in Tenovus Cancer Care shops and at events, an online shopping site and the use of Mobile Support Units for non-cancer services, with all profits being covenanted to Tenovus Cancer Care.”
Structured financials (annual return, FY ending 31/03/2025)
Trustees
- Tracey Mary Burkechair
- Alun Wyn Lloyd
- Dr Lucy Jay Swithenbank
- Dr Samantha Cox
- Dr Vivek Goel
- Iain Michael Edward Hardcastle
- Ian Tanter Thomas
- Imogen Margaret Olga Stringer
- Natasha Angus
- Rachel Dawn Holborrow
- Tina Michelle Gabb
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/03/2025 | £8.6m | £9.6m |
| 31/03/2024 | £9.7m | £8.8m |
| 31/03/2023 | £8.6m | £8.3m |
| 31/03/2022 | £8.5m | £7.3m |
| 31/03/2021 | £8.1m | £7.0m |
Common questions
Is TENOVUS CANCER CARE financially healthy?
The accounts state that the charity generated a surplus before investment gains of £858,239 and holds unrestricted reserves of £6.12m, which is above its stated policy target of £2.64m. The trustees confirmed that the use of the going concern basis of accounting is appropriate with no material uncertainties identified regarding the group's ability to continue. Its FY2024 accounts were audited by Advantage Accountancy and Advisory Limited.
Who funds TENOVUS CANCER CARE?
Funders whose own accounts filings name TENOVUS CANCER CARE as a grant recipient include BRCK Foundation, FOREST HILL CHARITABLE TRUST, TOYOTA MANUFACTURING UK CHARITABLE TRUST.
Known funders
| Funder | Year | Amount |
|---|---|---|
| BRCK Foundation | FY2025 | £4k |
| FOREST HILL CHARITABLE TRUST | FY2023 | £2k |
| TOYOTA MANUFACTURING UK CHARITABLE TRUST | FY2022 | £2k |
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| FRAZER TRUST | 3 | £6k |
| CBRE UK CHARITABLE TRUST | 3 | £3k |
| THE PENNIES FOUNDATION | 2 | £755k |
| E B M CHARITABLE TRUST | 2 | £95k |
| THE JOSEPH AND LILIAN SULLY FOUNDATION | 2 | £40k |
| CECIL PILKINGTON CHARITABLE TRUST | 2 | £24k |
| BNA CHARITABLE INCORPORATED ORGANISATION | 2 | £11k |
| SIR SAMUEL SCOTT OF YEWS TRUST | 2 | £6k |